Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Methodological considerations in the evaluation of radiotherapy technologies.

Burnet NG, Billingham LJ, Chan CS, Hall E, Macdougall J, Mackay RI, Maughan TS, Nutting CM, Staffurth JN, Illidge TM; National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Executive Group.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):707-9. doi: 10.1016/j.clon.2012.06.003. Epub 2012 Jul 12. No abstract available.

PMID:
22795231
2.

Low-dose radiotherapy of disease.

Pollycove M, Feinendegen LE.

Health Phys. 2011 Mar;100(3):322-4. No abstract available.

PMID:
21595082
3.

Particle radiotherapy.

Griffin TW.

Hosp Pract (Off Ed). 1985 Sep 15;20(9):91-5, 98-106. No abstract available.

PMID:
2993322
4.

Time-dose considerations for normal-tissue tolerance.

Thames HD, Peters LJ, Ang KK.

Front Radiat Ther Oncol. 1989;23:113-30. Review. No abstract available.

PMID:
2697649
5.

[Possibilities of clinical application of neutrons].

Breur K, van Peperzeel HA, Broerse JJ, Barendsen GW.

Bull Cancer. 1974 Oct-Dec;61(4):429-42. French. No abstract available.

PMID:
4617615
6.

Quality assurance of radiotherapy in clinical trials.

Glicksman AS, Reinstein LE, Laurie F.

Cancer Treat Rep. 1985 Oct;69(10):1199-205. No abstract available.

PMID:
4042099
7.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

8.

The potential role of proton beams in radiation oncology.

Loeffler JS, Smith AR, Suit HD.

Semin Oncol. 1997 Dec;24(6):686-95. Review.

PMID:
9422264
9.

Conformal radiotherapy: a clinical review.

Read G.

Clin Oncol (R Coll Radiol). 1998;10(5):288-96. Review. No abstract available.

PMID:
9848328
10.

[Biological effectiveness of a course of cancer radiation therapy and ways to express it].

Kholin VV, Frolova ZV.

Med Radiol (Mosk). 1972 Dec;17(12):64-74. Review. Russian. No abstract available.

PMID:
4618320
11.

Fractionation in radiotherapy.

Moonen L, Bartelink H.

Cancer Treat Rev. 1994 Oct;20(4):365-78. Review. No abstract available.

PMID:
7954492
12.

Dose-rate effects in targeted radiotherapy.

Dale RG.

Phys Med Biol. 1996 Oct;41(10):1871-84. Review.

PMID:
8912367
13.

Inherent acceleration of tumor dose-rate in hyperfractionated regimens.

Withers HR.

Int J Radiat Oncol Biol Phys. 1988 Feb;14(2):400. No abstract available.

PMID:
3338962
14.

Rationale for fractionated radiotherapy.

Kimler BF, Oliver LM.

Radiol Technol. 1980 May-Jun;51(6):809-14. No abstract available.

PMID:
7413963
15.

Mathematical modelling in the optimization of radiotherapy.

Ivanov VK, Konopliannikov AG, PetrovskiÄ­ AM, Khenkin EV.

Med Radiol (Mosk). 1977 May;22(5):27-33. Russian. No abstract available.

PMID:
875662
16.

Molecular targets for radiation therapy: bringing preclinical data into clinical trials.

Tofilon PJ, Saxman S, Coleman CN.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3518-20. No abstract available.

17.

Large-dose fractionation (hypofractionation).

Cox JD.

Cancer. 1985 May 1;55(9 Suppl):2105-11.

18.

Optimization of radiotherapy. Report of a WHO meeting of investigators.

[No authors listed]

World Health Organ Tech Rep Ser. 1980;644:1-89. No abstract available.

PMID:
6770556
19.

Relevance and irrelevance of DNA damage response to radiotherapy.

Connell PP, Kron SJ, Weichselbaum RR.

DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1245-51. Review.

PMID:
15279813
20.

Introduction: management of target localization uncertainties in external-beam therapy.

Mageras GS.

Semin Radiat Oncol. 2005 Jul;15(3):133-5. No abstract available.

PMID:
15983938
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk